Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Devices & Diagnostics Letter > Edwards 3Q Earnings Fall Short, Company Blames Medicare, Austerity

Devices & Diagnostics Letter

Oct. 15, 2012 | Vol. 39 No. 41

Edwards 3Q Earnings Fall Short, Company Blames Medicare, Austerity

Slowed uptake of the Sapien transcatheter heart valve led Edwards Lifesciences to issue advance warning last week of disappointing third-quarter sales.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

St. Jude, Spinal Modulation Ink $40M Distribution Deal on Pain Device Quest, Hologic Sign Five-Year Deal on Women’s Diagnostics Boston Scientific Whistleblower Suit Gets Green Light From Judge In Brief

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.